Highlights from Gene Solutions Indonesia exhibition at the Annual Scientific Meeting of the Indonesian Society of Obstetrics and Gynaecology (POGI)

  • News

Gene Solutions Indonesia participated in the Annual Scientific Meeting of the Indonesian Society of Obstetrics and Gynaecology (POGI), themed “Culture, Tradition, and Digital Challenge in Maternal Care.” This event, held from Monday to Wednesday, July 22-24, 2024, at Hotel Harper, East Nusa Tenggara, provided a platform for obstetricians and gynaecologists from across Indonesia to discuss and address emerging challenges in the medical field.

Photo: Gene Solutions Indonesia team at booth exhibition.
Photo: Gene Solutions Indonesia team at booth exhibition.

Attended the event as industry exhibition, Gene Solutions Indonesia highlighted our cutting-edge cell-free DNA testing innovations. Our focus included the unique non-invasive prenatal testing (NIPT) solutions for prenatal screening, as well as personalized precision oncology. The latter includes multi-cancer early detection and molecular diagnostics for gynaecological cancers. These advancements are designed to enhance maternal and child healthcare in Indonesia, addressing digital, cultural, and traditional obstacles.

Photo: Welcoming OBGYNs from across the country
Photo: Welcoming OBGYNs from across the country

Moreover, we demonstrated our commitment as dedicated partners to POGI by supporting the nationwide validation study conducted by POGI HKFM. Through this engagement, Gene Solutions Indonesia aims to collaborate with various obstetricians and gynaecologists, fostering an environment of learning and innovation, particularly in genomic testing.

Photo: Introduction of the study “Prevalence and Detection of Chromosomal Abnormalities and Thalassemia Carrier Status in High-risk Pregnancies in Indonesia”.
Photo: Introduction of the study “Prevalence and Detection of Chromosomal Abnormalities and Thalassemia Carrier Status in High-risk Pregnancies in Indonesia”.

This platform allowed us to share insights and experiences, reinforcing our dedication to empowering parents and reproductive health.

About Gene Solutions Indonesia:

Established in 2022, PT Gene Solutions Indonesia has been diligently advancing genetic testing and providing essential support to healthcare practitioners. We recognize the significance of Next-Generation Sequencing (NGS) in prenatal care and molecular diagnostics. Through our valued partnership with KALGen INNOLAB, we strive to make Non-Invasive Prenatal Testing (NIPT) and oncology diagnostics accessible to the Indonesian population.

Follow Gene Solutions Indonesia on Instagram to get latest update. https://www.instagram.com/genesolutions.id/

Facebook
Twitter
Pinterest

LATEST News

New Study Validates Gene Solutions’ Upgraded ctDNA Workflow Behind K-TRACK and K-4CARE

New Study Validates Gene Solutions’ Upgraded ctDNA Workflow Behind K-TRACK and K-4CARE

Peer-reviewed findings published in The Journal of Liquid Biopsy, an official journal of the International Society of Liquid Biopsy (ISLB), demonstrate broader ctDNA analysis, improved recurrence prediction, and greater flexibility with or without tumor tissue. SINGAPORE, 14 October 2026 – Gene Solutions announced the publication of a new peer-reviewed study validating the upgraded ctDNA workflow behind K-TRACK, K-4CARE, and K-TRACK Blood Only. Published in The Journal of Liquid Biopsy, an official journal of the International Society of Liquid Biopsy (ISLB), the study evaluated how Gene Solutions’ new hybrid-capture sequencing workflow and VarSURE bioinformatics pipeline improve upon its previous amplicon-based ctDNA method.

Read More

Biomarker and ctDNA Testing: A Personalized Approach to Cancer Care

Cancer diagnosis often brings many questions: Which treatment is most suitable for me? Is my treatment working? Has cancer changed? Could it come back? Every person’s cancer is different. Even when two people have the same type of cancer, their tumors may have different biological features. These differences can influence how the cancer behaves and how it responds to treatment. Biomarker and circulating tumor DNA, or ctDNA, testing may help doctors better understand these differences. Together, these tests may support more personalized treatment decisions and provide additional information as the cancer changes over time. Why can the same cancer respond

Read More
Gene Solutions NIPT preterm birth prenatal health

Gene Solutions Study Finds Preterm-Birth Signals in Routine triSure NIPT Data

A Gene Solutions study published in American Journal of Obstetrics & Gynecology (AJOG) Global Reports finds cell-free DNA fragmentomic patterns associated with spontaneous preterm birth, pointing to a potential path toward earlier pregnancy-risk assessment. SINGAPORE, Sept. 25, 2026 /PRNewswire/ — Gene Solutions, a global biotechnology company providing precision cell-free DNA solutions through multi-omics and artificial intelligence to improve pregnancy care, cancer detection and precision medicine, today announced the publication of a study showing the potential to assess the risk of spontaneous preterm birth from cell-free DNA fragmentomic signals already present in routine first-trimester non-invasive prenatal testing (NIPT) data. Published in AJOG Global Reports, the

Read More